Showing results (321-330 of 337) with videos related to

Sort By:
Pageof 34
Leukemia|October 14, 2014
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemiasM L Tursky, D Beck, J A I Thoms, et al.
Plos Genetics|June 24, 2011
SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stabilityGlenn M Marshall, Pei Y Liu, Samuele Gherardi, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 18, 2025
No altitude required: differential ventilatory and blood acid-base homeostasis between unacclimatized lowlanders and Tibetan highlanders at 1,400 mNicole V Bushfield, Nicole A Johnson, Jessica A Dickenson, et al.
Biochemical Pharmacology|January 18, 2014
A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cellsStephen M F Jamieson, Yongchuan Gu, Donya Moradi Manesh, et al.
Nucleic Acids Research|September 9, 2016
A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an ERG-driven transcriptional networkAshwin Unnikrishnan, Yi F Guan, Yizhou Huang, et al.
Cancer Research|May 20, 2016
MYC-Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of DyskerinRosemary O'Brien, Sieu L Tran, Michelle F Maritz, et al.
Nature Communications|December 23, 2025
Large-scale drug sensitivity, gene dependency, and proteogenomic analyses of telomere maintenance mechanisms in cancer cellsYangxiu Wu, Zhaoxiang Cai, Dale Cross, et al.
Cancer Research|October 17, 2015
WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in NeuroblastomaYuting Sun, Jessica L Bell, Daniel Carter, et al.
Seminars in Cancer Biology|April 15, 2015
Therapeutic targeting of replicative immortalityPaul Yaswen, Karen L MacKenzie, W Nicol Keith, et al.
Gates Open Research|May 26, 2022
Global research and learning agenda for building evidence on contraceptive-induced menstrual changes for research, product development, policies, and programsEmily Hoppes, Chukwuemeka Nwachukwu, Julie Hennegan, et al.
Pageof 34